Gly-β-MCA
CAS No. 66225-78-3
Gly-β-MCA( —— )
Catalog No. M32942 CAS No. 66225-78-3
Gly-β-MCA is an orally bioactive, enteroselective and potent inhibitor of the farnesoid X receptor (FXR), a bile acid, used in the study of obesity and diabetes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 302 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGly-β-MCA
-
NoteResearch use only, not for human use.
-
Brief DescriptionGly-β-MCA is an orally bioactive, enteroselective and potent inhibitor of the farnesoid X receptor (FXR), a bile acid, used in the study of obesity and diabetes.
-
DescriptionGly-β-MCA, a bile acid, is a potent, sable, intestine-selective and oral bioactive farnesoid X receptor (FXR) inhibitor that may be a candidate for the treatment of metabolic disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetFXR
-
RecptorFXR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number66225-78-3
-
Formula Weight465.62
-
Molecular FormulaC26H43NO6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (214.77 mM; Ultrasonic ) H2O : < 0.1 mg/mL (insoluble)
-
SMILESC[C@H](CCC(=O)NCC(O)=O)C1CCC2C3[C@@H](O)[C@@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)C3CC[C@]12C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jiang C, et al. Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction. Nat Commun. 2015 Dec 15;6:10166.?
molnova catalog
related products
-
Vonafexor
Vonafexor (EYP001) is a selective?FXR?agonist with anti-HBV effects.
-
LY-2562175
LY-2562175 (LY2562175, LY 2562175) is a novel potent, selective, partial FXR agonist with EC50 of 193 nM.
-
Nidufexor
Nidufexor (LMB763, LMB-763) is a novel potent farnesoid X receptor (FXR) agonist?for the treatment of non-alcoholic steatohepatitis (NASH) and hepatobiliary disorders.
Cart
sales@molnova.com